secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2024-10-25T23:59:59+00:00
Accession:  0001493152-24-042462
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma closes second tranche of $1.3M note offering, total $790K raised
-------------------------------------------------------------------------------

- Second closing on Oct 21 added $220K net proceeds ($231,579 in Notes) from two accredited investors.
- Investors received 88,544 warrants exercisable at $1.49/share (125% of prior closing price).
- CEO Dr. Anatoly Dritschilo invested $237,500 in the first closing on Oct 14.
- Total offering gross proceeds $790K; Notes carry 5% OID and are senior secured convertible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224042462/0001493152-24-042462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224042462/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer